Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | the activity of KLK12 can be tightly regulated by autodegradation, by interaction with zinc ions, and by covalent complex formation with alpha2-antiplasmin | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
24500 | - |
x * 24500, calculated from amino acid sequence | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
CCN1 protein + H2O | Homo sapiens | i.e. (cyr61,ctgf, nov), the main cleavage site is localized in the hinge region between the first and second half of the recombinant protein at Lys88-Gly89, Lys208-Arg209, Arg218-Ile219, Lys291-Lys292, and Lys345-Asn346 | ? | - |
? | |
CCN2 protein + H2O | Homo sapiens | - |
? | - |
? | |
CCN3 protein + H2O | Homo sapiens | - |
? | - |
? | |
CCN4 protein + H2O | Homo sapiens | - |
? | - |
? | |
CCN5 protein + H2O | Homo sapiens | cleavage site is at Arg215-Val216 | ? | - |
? | |
CCN6 protein + H2O | Homo sapiens | - |
? | - |
? | |
additional information | Homo sapiens | active KLK12 possesses trypsin-like activity, targeting peptide bonds featuring either arginine or lysine at their P1 position | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9UKR0 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
bone | - |
Homo sapiens | - |
bone marrow | - |
Homo sapiens | - |
colon | - |
Homo sapiens | - |
lung | - |
Homo sapiens | - |
lung cancer cell | - |
Homo sapiens | - |
prostate | - |
Homo sapiens | - |
salivary gland | - |
Homo sapiens | - |
stomach | - |
Homo sapiens | - |
trachea | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
CCN1 protein + H2O | i.e. (cyr61,ctgf, nov), the main cleavage site is localized in the hinge region between the first and second half of the recombinant protein at Lys88-Gly89, Lys208-Arg209, Arg218-Ile219, Lys291-Lys292, and Lys345-Asn346 | Homo sapiens | ? | - |
? | |
CCN2 protein + H2O | - |
Homo sapiens | ? | - |
? | |
CCN3 protein + H2O | - |
Homo sapiens | ? | - |
? | |
CCN4 protein + H2O | - |
Homo sapiens | ? | - |
? | |
CCN5 protein + H2O | cleavage site is at Arg215-Val216 | Homo sapiens | ? | - |
? | |
CCN6 protein + H2O | - |
Homo sapiens | ? | - |
? | |
additional information | active KLK12 possesses trypsin-like activity, targeting peptide bonds featuring either arginine or lysine at their P1 position | Homo sapiens | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 24500, calculated from amino acid sequence | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
kallikrein-related peptidase 12 | - |
Homo sapiens |
KLK12 | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | KLK12 expression is increased in lung tumor | up |
General Information | Comment | Organism |
---|---|---|
physiological function | fragmentation of CCN1 or CCN5 by KLK12 prevents vascular endothelial growth factor165 binding, whereas it also triggers the release of intact vascular endothelial growth factor and bone morphogenetic protein 2 from the CCN protein complexes. The KLK12-mediated release of transforming growth factor-beta1 and fibroblast growth factor-2 is concentration-dependent. KLK12 may indirectly regulate the bioavailability and activity of several growth factors through processing of their CCN binding partners | Homo sapiens |